FCM
VIRX

Farallon Capital Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Farallon Capital Management’s Portfolio VIRX Stock Details VIRX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
2015
Q3 		$2.49M Buy
2015
Q2 		$6.51M Buy
2014
Q3 		– Sell
2014
Q2 		$4.37M Sell
2014
Q1 		$10.6M Buy
2013
Q4 		$4.98M Buy
2013
Q3 		$3.55M Buy
2013
Q2 		$2.48M Buy